AlisonSchecterMD

Adjunct Associate Professor, Medicine - Cardiology, Icahn School of Medicine at Mount Sinai

Dr. Schecter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1994 - 1996
Johns Hopkins UniversityResidency, Internal Medicine, 1990 - 1993
State University of New York Downstate Medical Center College of MedicineClass of 1990

PubMed

15 citations
Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy
Simon Jones, Margaret M. McGovern, Olivier Lidove, Roberto Giugliani, Pramod K. Mistry
Molecular Genetics and Metabolism. 2020-06-24
39 citations
SDF-1 induces TNF-mediated apoptosis in cardiac myocytes.
Andrew A. Jarrah, Martina Schwarskopf, Edward R. Wang, Thomas J. LaRocca, Ashwini Dhume
Apoptosis. 2018-01-01
77 citations
Arterial effects of canakinumab in patients with atherosclerosis and type 2 diabetes or glucose intolerance
Robin P. Choudhury, Jacqueline Birks, Venkatesh Mani, Luca Biasiolli, Matthew D. Robson
Journal of the American College of Cardiology. 2016-10-18

Predicting Long COVID: Who’s at Risk?March 6th, 2022
AXA1125 – a New Mitochondrial Enhancer Is Being Trialed in Long COVIDNovember 5th, 2021
Axcella Therapeutics Launches Clinical Program to Develop Treatment for Patients with Long COVIDOctober 26th, 2021
Join now to see all